NXTD yields 82.64% · JNJ yields 2.13%● Live data
📍 NXTD pulled ahead of the other in Year 1
Combined, NXTD + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NXTD + JNJ for your $10,000?
Nxt-ID, Inc. provides technology products and services for healthcare applications. It develops and markets solutions for payment, Internet of Things (IoT), and healthcare applications with experience in access control, biometric and behavior-metric identity verification, security and privacy, encryption and data protection, payments, miniaturization, and sensor technologies. The company, through its subsidiary, LogicMark LLC, manufactures and distributes non-monitored and monitored personal emergency response systems sold through healthcare durable medical equipment and monitored security dealers/distributors, and the United States Department of Veterans Affairs. It serves various end markets, including the security, healthcare, financial technology, and the IoT markets. Nxt-ID, Inc. was founded in 2011 and is based in Oxford, Connecticut.
Full NXTD Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.